Everolimus

What Everolimus Means in Everyday Medical Language

Everolimus is a medicine that helps slow or stop the growth of certain tumors by blocking a protein called mTOR. This protein plays an important role in how cells grow, divide, and form new blood vessels. By blocking mTOR, everolimus can help control the growth of cancer cells and some non-cancerous tumors. It is a type of targeted therapy, which means it focuses on specific parts of cells involved in tumor growth, rather than affecting many cells like traditional chemotherapy.

Everolimus is sold under several brand names, including Afinitor, Afinitor Disperz, and Zortress. Afinitor is mainly used to treat cancers such as breast cancer, kidney cancer, and neuroendocrine tumors. Afinitor Disperz is used mostly for certain non-cancerous brain tumors and seizures related to tuberous sclerosis, a genetic condition that causes growths in organs like the brain and kidneys. Zortress is used to prevent the body from rejecting transplanted organs like kidneys or livers.

Why Everolimus Can Matter in Cancer Care

Everolimus offers a treatment option for cancers and tumors that may not respond well to other therapies. By targeting mTOR, it helps slow tumor growth and reduces the formation of new blood vessels that tumors need to survive. This can help control the disease, improve symptoms, and potentially slow progression. It is approved for use in several cancers, including advanced breast cancer, kidney cancer, and certain neuroendocrine tumors that cannot be removed by surgery or have spread.

In addition to cancer, everolimus helps manage some benign tumors and seizures in people with tuberous sclerosis. Its ability to target specific pathways in cells makes it a valuable option when surgery is not possible or other treatments are not suitable.

What Patients Might See or Hear About Everolimus

Patients may hear the name everolimus or its brand names like Afinitor or Afinitor Disperz during discussions about treatment options, in medical reports, or on clinical trial pages. Seeing these names does not always mean cancer is present, especially with Afinitor Disperz, which is used for non-cancerous tumors and seizure control in tuberous sclerosis.

Everolimus may also appear as RAD001 in some reports or research. Because of these different names, it’s helpful to ask your healthcare team what the drug means in your specific case and how it fits into your treatment plan.

Common Questions to Ask Your Care Team

If everolimus is mentioned as part of your care, you might ask how it works for your specific condition, what side effects to expect, and how they can be managed. It’s also useful to ask whether it will be used alone or with other treatments, how your response to the drug will be monitored, and if there are any lifestyle changes you should consider while taking it.

Understanding Everolimus in Context and Safety Information

It’s important to know that everolimus is not a cure but a way to help control tumor growth and improve quality of life. Its use depends on the type of cancer or condition, disease stage, and how a patient responds to other treatments. This information is educational and does not replace medical advice. Always discuss your specific situation and treatment options with your healthcare provider.

Next Steps for Patients and Caregivers

If you see everolimus mentioned in your medical records or hear about it from your care team, the best next step is to ask how it relates to your diagnosis and treatment plan. Understanding what the drug does and how it fits into your care can help you feel more confident and involved in decisions about your health.